What is the current Price Target for the MediciNova, Inc. stock?

The average MediciNova, Inc. target price is $7.14. This is 445.04% higher than the current stock price. The highest price target is 621.37%, the lowest is 285.50%. 4 Analysts have issued a price target MediciNova, Inc. 2026 .

How high will the MediciNova, Inc. stock rise?

No reliable answer can be given as to how high the MediciNova, Inc. stock will rise. The performance of stocks, including the MediciNova, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the MediciNova, Inc. stock today?

The performance of MediciNova, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the MediciNova, Inc. stock fall?

The decline in MediciNova, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

MediciNova, Inc. Forecast, price target & analysts

$1.31

0.00%

Nasdaq, Sep 02, 10:00 pm CET

ISIN

US58468P2065

Symbol

MNOV

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

MediciNova, Inc. Target price 2025 - Analyst rating & recommendation

MediciNova, Inc. Classifications & Recommendation:

Buy

88%

Hold

13%

MediciNova, Inc. Price Target

Target Price	$7.14
Price	$1.31
Potential	445.04% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target MediciNova, Inc. 2026 . The average MediciNova, Inc. target price is $7.14. This is 445.04% register free of charge higher than the current stock price. The highest price target is $9.45 621.37% register free of charge , the lowest is $5.05 285.50% register free of charge .
	A rating was issued by 8 analysts: 7 Analysts recommend MediciNova, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the MediciNova, Inc. stock has an average upside potential 2026 of 445.04% register free of charge . Most analysts recommend the MediciNova, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-0.23	-0.41
	35.29%	78.26%
P/E		negative

4 Analysts have issued a MediciNova, Inc. forecast for earnings per share. The average MediciNova, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.23	35.29%
2025	$-0.41 78.26% Unlock
2026	$-0.36 12.20% Unlock
2027	$-0.41 13.89% Unlock
2028	$-0.45 9.76% Unlock
2029	$-0.06 86.67% Unlock
2030	$0.99 1,750.00% Unlock
2031	$4.29 333.33% Unlock
2032	$6.67 55.48% Unlock

Current	-7.28	19.23%
2025	-3.21 55.89% Unlock
2026	-3.62 12.77% Unlock
2027	-3.21 11.33% Unlock
2028	-2.92 9.03% Unlock
2029	-21.41 633.22% Unlock
2030	1.32 106.17% Unlock
2031	0.31 76.52% Unlock
2032	0.20 35.48% Unlock

MediciNova, Inc....

Current MediciNova, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
D. Boral Capital	Locked ➜ Locked	Locked	Aug 27 2025
D. Boral Capital	Locked ➜ Locked	Locked	Jul 24 2025
B. Riley Securities	Locked ➜ Locked	Locked	Jun 16 2025
D. Boral Capital	Locked ➜ Locked	Locked	Apr 09 2025
D. Boral Capital	Locked ➜ Locked	Locked	Mar 14 2025
D. Boral Capital	Locked ➜ Locked	Locked	Feb 21 2025
D. Boral Capital	Locked ➜ Locked	Locked	Dec 06 2024

Analyst Rating	Date
Locked D. Boral Capital: Locked ➜ Locked	Aug 27 2025
Locked D. Boral Capital: Locked ➜ Locked	Jul 24 2025
Locked B. Riley Securities: Locked ➜ Locked	Jun 16 2025
Locked D. Boral Capital: Locked ➜ Locked	Apr 09 2025
Locked D. Boral Capital: Locked ➜ Locked	Mar 14 2025
Locked D. Boral Capital: Locked ➜ Locked	Feb 21 2025
Locked D. Boral Capital: Locked ➜ Locked	Dec 06 2024

Discover more stocks with a high price target

Adidas 49.18%

BYD 45.13%

Novo Nordisk 42.28%

BioNTech SE - ADR 38.37%

Coinbase Global, Inc. 26.00%

Deutsche Telekom 23.44%

Rheinmetall 21.95%

Meta Platforms (Facebook) 20.72%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now